OmniStar Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.37M | Buy |
58,507
+4,345
| +8% | +$249K | 1.55% | 16 |
|
|
2026
Q1 | $3.28M | Buy |
+54,162
| New | +$3.16M | 1.7% | 13 |
|
|
2025
Q3 | – | Sell |
-14,978
| Closed | -$693K | – | 116 |
|
|
2025
Q2 | $693K | Buy |
14,978
+1,826
| +14% | +$89.6K | 0.52% | 57 |
|
|
2025
Q1 | $802K | Buy |
+13,152
| New | +$767K | 0.63% | 52 |
|
|
2024
Q3 | – | Sell |
-13,316
| Closed | -$553K | – | 128 |
|
|
2024
Q2 | $553K | Buy |
13,316
+224
| +2% | +$10K | 0.5% | 84 |
|
|
2024
Q1 | $710K | Sell |
13,092
-3,000
| -19% | -$153K | 0.65% | 55 |
|
|
2023
Q4 | $826K | Sell |
16,092
-5,981
| -27% | -$314K | 1.04% | 30 |
|
|
2023
Q3 | $1.28M | Buy |
22,073
+2,437
| +12% | +$149K | 1.52% | 14 |
|
|
2023
Q2 | $1.26M | Buy |
19,636
+1,279
| +7% | +$85.8K | 1.48% | 17 |
|
|
2023
Q1 | $1.27M | Buy |
18,357
+1,417
| +8% | +$99.9K | 1.61% | 14 |
|
|
2022
Q4 | $1.22M | Buy |
16,940
+468
| +3% | +$35.3K | 1.38% | 22 |
|
|
2022
Q3 | $1.17M | Sell |
16,472
-2,703
| -14% | -$196K | 1.4% | 21 |
|
|
2022
Q2 | $1.48M | Buy |
19,175
+1,896
| +11% | +$144K | 1.64% | 14 |
|
|
2022
Q1 | $1.26M | Sell |
17,279
-3,863
| -18% | -$259K | 1.25% | 24 |
|
|
2021
Q4 | $1.32M | Buy |
21,142
+1,426
| +7% | +$83.7K | 1.35% | 24 |
|
|
2021
Q3 | $1.17M | Buy |
+19,716
| New | +$1.3M | 1.38% | 20 |
|
|
2021
Q2 | – | Sell |
-18,278
| Closed | -$1.19M | – | 114 |
|
|
2021
Q1 | $1.15M | Sell |
18,278
-12,482
| -41% | -$777K | 1.47% | 17 |
|
|
2020
Q4 | $1.91M | Sell |
30,760
-11,435
| -27% | -$703K | 1.34% | 24 |
|
|
2020
Q3 | $2.54M | Buy |
42,195
+510
| +1% | +$30.7K | 1.92% | 13 |
|
|
2020
Q2 | $2.45M | Buy |
41,685
+19,397
| +87% | +$1.16M | 2.03% | 10 |
|
|
2020
Q1 | $1.24M | Buy |
22,288
+8,123
| +57% | +$496K | 1.22% | 25 |
|
|
2019
Q4 | $909K | Sell |
14,165
-13,129
| -48% | -$752K | 0.77% | 51 |
|
|
2019
Q3 | $1.38M | Sell |
27,294
-483
| -2% | -$22.7K | 1.21% | 31 |
|
|
2019
Q2 | $1.26M | Sell |
27,777
-317
| -1% | -$14.8K | 1.13% | 36 |
|
|
2019
Q1 | $1.34M | Buy |
28,094
+6,393
| +29% | +$318K | 1.18% | 36 |
|
|
2018
Q4 | $1.13M | Buy |
21,701
+1,822
| +9% | +$97.9K | 1.15% | 37 |
|
|
2018
Q3 | $1.23M | Buy |
+19,879
| New | +$1.18M | 0.94% | 42 |
|
Other funds holding BMY
OmniStar Financial Group's BMY Position: Q2 2026 in Review
OmniStar Financial Group increased its Bristol-Myers Squibb (BMY) stake by 8% in Q2 2026, buying an estimated $249K and bringing the position to 58,507 shares worth $3.37M. The position accounts for 1.55% of the portfolio, ranked #16.
OmniStar Financial Group first reported a position in BMY in Q3 2018 and has held it in 27 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- OmniStar Financial Group held 58,507 shares of Bristol-Myers Squibb worth $3.37M as of Q2 2026.
- OmniStar Financial Group bought 4,345 Bristol-Myers Squibb shares in Q2 2026, an estimated $249K.
- Bristol-Myers Squibb made up 1.55% of OmniStar Financial Group's portfolio in Q2 2026, its #16 holding.
- OmniStar Financial Group first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 27 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.